全球放射肿瘤学市场

预计到 2030 年全球放射肿瘤学市场规模将达到 102 亿美元

全球放射肿瘤学市场规模预计在2024年达到79亿美元，预计在2024-2030年的分析期间将以4.3%的复合年增长率成长，到2030年将达到102亿美元。体外放射线治疗是本报告分析的细分市场之一，预计其复合年增长率为3.3%，到分析期结束时规模将达到36亿美元。近距离放射治疗细分市场在分析期间的复合年增长率预计为5.5%。

美国市场预计将达到 22 亿美元，中国市场复合年增长率将达到 7.6%

美国放射肿瘤学市场规模预计2024年达到22亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到21亿美元，在2024-2030年的分析期间内，复合年增长率为7.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.8%和3.3%。在欧洲，预计德国市场的复合年增长率为2.5%。

全球放射肿瘤学市场—主要趋势与驱动因素摘要

放射肿瘤学如何发展以满足癌症治疗的需求？

放射肿瘤学仍然是癌症多学科治疗的基石，技术创新不断提高针对恶性组织的疗效和精确度。该领域正在经历从传统放射治疗向强度调控放射治疗(IMRT)、立体定位放射线手术(SRS)、影像导航放射治疗(IGRT) 和质子治疗等先进技术的重大转变。这些治疗方法能够精准输送剂量，保护周围健康组织，减少副作用，并改善患者预后。全球癌症发生率的上升和人口老化迫使医疗保健系统扩展其放射肿瘤学基础设施和能力。

个人化肿瘤治疗（根据肿瘤基因和放射学数据客製化治疗方案）的采用正在进一步重新定义治疗计划。人工智慧和机器学习演算法与放射肿瘤学软体的整合促进了自适应放射治疗，该疗法可根据患者反应和解剖变异即时调整治疗方案。此外，放射生物学和低分割通讯协定的进步使得缩短治疗时间并保持同等或更高的疗效成为可能，从而提高了治疗量并方便了患者。这些发展正在推动全球放射肿瘤学中心的临床和营运转型。

哪些技术和模式正在塑造现代放射肿瘤学实践？

直线加速器、质子治疗机、近距离放射治疗设备和机器人放射放射线手术平台正日益受到关注。直线加速器系统现已整合多叶准直器 (MLC)、容积调强弧形治疗 (VMAT) 和机载成像技术，能够以更少的治疗次数实现精准的肿瘤标靶治疗。质子治疗将大部分能量聚焦于布拉格峰，最大限度地减少附带损伤并降低长期毒性，在儿童癌症和复杂肿瘤病例中正迅速获得认可。

此外，诸如呼吸门控和即时肿瘤追踪等运动管理技术正被纳入治疗方案，以应对治疗过程中的器官运动问题，尤其是在肺癌和胃肠道癌症治疗中。近距离放射治疗因其能够提供高度局部化的剂量和较短的治疗时间，在子宫颈癌、前列腺癌和乳癌等癌症治疗中重新引起了人们的兴趣。将MRI和PET影像纳入治疗计画系统，可增强肿瘤可视化和自适应治疗计画。此外，标靶放射性核治疗中的新型放射性药物正在扩大转移性癌症（尤其是前列腺癌和神经内分泌肿瘤）的治疗选择。

医院和癌症中心如何面对放射肿瘤学革命？

放射肿瘤科正在进行重大升级，以适应新技术、工作流程自动化和多学科整合。医院正在投资混合手术室、先进的治疗计划软体和肿瘤资讯系统 (OIS)，以简化患者数据管理和治疗结果追踪。此外，放射肿瘤科医师、医学物理学家、剂量师和 IT 专业人员之间的合作正在正式化为跨职能团队，以优化治疗计划和实施。学术医疗中心在实施 AI 引导的自适应计划工具和云端基础的轮廓绘製平台方面处于主导地位，旨在缩短计划时间并提高准确性。

培训和员工发展也是适应的关键组成部分。现代放射治疗的复杂性要求在影像判读、机器校准和网路化肿瘤系统网路安全等领域不断提升技能。此外，医院正在采用以患者为中心的模式，将心理社会支持、症状追踪和远距会诊整合到放射肿瘤科的诊疗路径中。全球肿瘤网路和远距放射平台正在帮助将先进的放射治疗服务扩展到服务不足的地区，并缩小癌症治疗的可及性差距。这些营运和临床升级对于放射肿瘤科从特定程序方法向完全整合的数据主导型诊疗模式的演变至关重要。

放射肿瘤学市场的主要成长动力是什么？

放射肿瘤学市场的成长受到多种因素的推动，包括全球癌症发生率的上升、放射治疗技术的进步以及医疗机构对肿瘤学基础设施的持续投资。复杂且抗治疗性癌症的增多，推动了对质子治疗和立体定位放射治疗等精准治疗的需求。同时，人工智慧、影像处理和放射治疗技术的整合正在促进个人化治疗计划和疗效监测，从而提高临床疗效和业务效率。

政府资助和官民合作关係正在加速已开发地区和新兴地区的放射治疗基础设施建设。此外，先进放射治疗的保险覆盖范围不断扩大，以及人们对早期癌症检测意识的不断提升，也推动了该疗法的广泛应用。探索免疫疗法和放射线治疗新型组合的临床试验正在进行中，预计未来几年将出现新的治疗前沿。这些因素共同使放射肿瘤学不仅成为现代癌症治疗的基石，也成为一个不断经历技术和临床创新的领域，并有望在全球范围内实现显着增长。

部分

治疗类型（外束放射线治疗、近距离放射治疗、全身放射线治疗、立体定位放射线手术）、技术（线性加速器技术、放射性同位素技术、粒子治疗技术、断层治疗技术）、用途（乳癌用途、前列腺癌用途、肺癌用途、脑肿瘤用途、头颈癌用途）、最终用途（医院最终用途、门诊最终用途、癌症研究机构最终用途、门诊手术中心最终用途

受访公司范例

• Accuray Incorporated
• Bionix Radiation Therapy, LLC
• Brainlab AG
• Canon Medical Systems Corporation
• Curium
• Eckert & Ziegler BEBIG
• Elekta AB
• GE Healthcare
• Hitachi Ltd.
• IBA（Ion Beam Applications SA）
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nanobiotix
• Nordion Inc.
• Optivus Proton Therapy Inc.
• Panacea Medical Technologies Pvt. Ltd.
• RefleXion Medical
• RaySearch Laboratories AB
• Siemens Healthineers AG
• Sirtex Medical Limited
• Varian Medical Systems（Siemens）
• ViewRay Technologies, Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Radiation Oncology Market to Reach US$10.2 Billion by 2030

The global market for Radiation Oncology estimated at US$7.9 Billion in the year 2024, is expected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Brachytherapy segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 7.6% CAGR

The Radiation Oncology market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Radiation Oncology Market - Key Trends & Drivers Summarized

How Is Radiation Oncology Evolving in Response to Cancer Care Demands?

Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and capabilities.

The adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers globally.

Which Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?

Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term toxicity.

Furthermore, motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine tumors.

How Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?

Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning time.

Training and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology’s evolution from a procedural specialty into a fully integrated, data-driven care model.

What Are the Key Growth Drivers of the Radiation Oncology Market?

The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational efficiency.

Government funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally.

SCOPE OF STUDY:

The report analyzes the Radiation Oncology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery); Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology); Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application); End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Accuray Incorporated
• Bionix Radiation Therapy, LLC
• Brainlab AG
• Canon Medical Systems Corporation
• Curium
• Eckert & Ziegler BEBIG
• Elekta AB
• GE Healthcare
• Hitachi Ltd.
• IBA (Ion Beam Applications SA)
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nanobiotix
• Nordion Inc.
• Optivus Proton Therapy Inc.
• Panacea Medical Technologies Pvt. Ltd.
• RefleXion Medical
• RaySearch Laboratories AB
• Siemens Healthineers AG
• Sirtex Medical Limited
• Varian Medical Systems (Siemens)
• ViewRay Technologies, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities
  • Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities
  • Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake
  • Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions
  • Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors
  • Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure
  • Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches
  • Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility
  • Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput
  • Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes
  • Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms
  • Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration
  • Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools
  • Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols
  • Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization
  • Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability
  • Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration
  • Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines
  • Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth
  • AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Radiation Oncology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for External Beam Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Systemic Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Stereotactic Radiosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Head & Neck Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Outpatient Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Cancer Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Linear Accelerators Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Radioisotopes Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Particle Therapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Tomotherapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: USA 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Canada 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• JAPAN
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Japan 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• CHINA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: China 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• EUROPE
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• FRANCE
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 119: France Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: France 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• GERMANY
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Germany 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Italy 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 155: UK Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: UK 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Spain 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Russia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Australia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• INDIA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 230: India Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: India 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: South Korea 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Argentina 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Brazil 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Mexico 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Iran 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Israel 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: UAE 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• AFRICA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 412: Africa 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030

IV. COMPETITION